Akari Therapeutics, Plc (AKTX)
Total Valuation
AKTX has a market cap or net worth of $16.53 million. The enterprise value is $9.35 million.
| Market Cap | 16.53M |
| Enterprise Value | 9.35M |
Important Dates
The next estimated earnings date is Monday, February 5, 2024, before market open.
| Earnings Date | Feb 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
AKTX has 5.30 million shares outstanding.
| Shares Outstanding | 5.30M |
| Owned by Insiders (%) | 16.72% |
| Owned by Institutions (%) | 5.44% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 5.94 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.53, with zero debt.
| Current Ratio | 1.53 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -178.10% and return on invested capital (ROIC) is -763.54%.
| Return on Equity (ROE) | -178.10% |
| Return on Assets (ROA) | -102.00% |
| Return on Capital (ROIC) | -763.54% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$659,353 |
| Employee Count | 15 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.55% in the last 52 weeks. The beta is 1.13, so AKTX's price volatility has been higher than the market average.
| Beta (1Y) | 1.13 |
| 52-Week Price Change | -64.55% |
| 50-Day Moving Average | 3.23 |
| 200-Day Moving Average | 3.65 |
| Relative Strength Index (RSI) | 51.34 |
| Average Volume (30 Days) | 11,443 |
Short Selling Information
| Short Interest | 1,678 |
| Short Previous Month | 3,388 |
| Short % of Shares Out | 0.19% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.19 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -21.24M |
| Pretax Income | -9.89M |
| Net Income | -9.89M |
| EBITDA | -9.89M |
| EBIT | -9.89M |
| Earnings Per Share (EPS) | -$2.52 |
Balance Sheet
The company has $7.18 million in cash and no debt, giving a net cash position of $7.18 million or $1.36 per share.
| Cash & Cash Equivalents | 7.18M |
| Total Debt | n/a |
| Net Cash | 7.18M |
| Net Cash Per Share | $1.36 |
| Equity / Book Value | 2.78M |
| Book Value Per Share | 0.53 |
| Working Capital | 2.77M |
Cash Flow
| Operating Cash Flow | -17.45M |
| Capital Expenditures | n/a |
| Free Cash Flow | -17.45M |
| FCF Per Share | -$3.97 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AKTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -59.84% |
| FCF Yield | -105.61% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -104.73% |
| Shareholder Yield | -104.73% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 17, 2023. It was a reverse split with a ratio of 1:20.
| Last Split Date | Aug 17, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |